Literature DB >> 6965442

Comparison of cotrimoxazole, ampicillin, and chloramphenicol in treatment of experimental Haemophilus influenzae type B meningitis.

J R Perfect, S D Lang, D T Durack.   

Abstract

To evaluate cotrimoxazole in the treatment of bacterial meningitis, we compared its action with that of ampicillin and chloramphenicol in experimental Haemophilus influenzae type b meningitis. Both trimethoprim and sulfamethoxazole penetrated well into the cerebrospinal fluid of infected rabbits, reaching 40 and 26%, respectively, of their simultaneous serum levels. Levels measured 30 and 60 min after intravenous injection exceeded the minimum inhibitory concentration of this combination for H. influenzae by 10- to 100-fold. The mean ratio of trimethoprim to sulfamethoxazole in cerebrospinal fluid was 1:22. Cotrimoxazole was as effective as ampicillin in therapy of beta-lactamase-negative H. influenzae meningitis and as effective as chloramphenicol for a beta-lactamase positive strain. These findings corroborate favorable preliminary clinical experience reported by others and indicate that cotrimoxazole deserves further study in the therapy of bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965442      PMCID: PMC283724          DOI: 10.1128/AAC.17.1.43

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Gram-negative bacillary meningitis.

Authors:  R J Mangi; R Quintiliani; V T Andriole
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

2.  Cerebrospinal fluid cotrimoxazole levels.

Authors:  W O Kirwan
Journal:  J Ir Med Assoc       Date:  1974-02-09

3.  Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis.

Authors:  J F Wallace; R H Smith; M Garcia; R G Petersdorf
Journal:  J Lab Clin Med       Date:  1967-09

4.  Letter: Ampicillin-resistant Haemophilus influenzae meningitis.

Authors:  W J Thomas; J W McReynolds; C R Mock; D W Bailey
Journal:  Lancet       Date:  1974-02-23       Impact factor: 79.321

5.  [Clinical experiences and pharmacokinetic studies on Bactrim "Roche" in meningitis].

Authors:  S Kaufmann; R Hennes
Journal:  Med Welt       Date:  1973-11-30

6.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

7.  Meningitis due to Hemophilus influenzae: long-term sequelae.

Authors:  E T Sproles; J Azerrad; C Williamson; R E Merrill
Journal:  J Pediatr       Date:  1969-11       Impact factor: 4.406

8.  Treatment of meningitis and septicemia in infancy with a sulphamethoxazole/trimethorpim combination.

Authors:  K G Sabel; A Brandberg
Journal:  Acta Paediatr Scand       Date:  1975-01

9.  Susceptibility of Haemophilus influenzae isolates from blood and cerebrospinal fluid to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.

Authors:  J E McGowan; P M Terry; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

10.  Haemophilus influenzae infections in adults: report of nine cases and a review of the literature.

Authors:  J V Hirschmann; E D Everett
Journal:  Medicine (Baltimore)       Date:  1979-01       Impact factor: 1.889

View more
  5 in total

1.  Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.

Authors:  Y Sakata; G H McCracken; M L Thomas; K D Olsen
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

2.  Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.

Authors:  G H McCracken; J D Nelson; L Grimm
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

Review 3.  Bacterial meningitis. Rational selection and use of antibacterial drugs.

Authors:  M Whitby; R Finch
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

4.  Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.

Authors:  M N Dudley; R E Levitz; R Quintiliani; J M Hickingbotham; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

5.  Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.

Authors:  J M Mylotte; T R Bates; K A Sergeant; R E Matson; T R Beam
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.